Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2011-08-30
2011-08-30
Shen, Wu-Cheng Winston (Department: 1632)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S024300, C435S320100
Reexamination Certificate
active
08008460
ABSTRACT:
Nucleotide sequences and fragments which code for a human endogenous retrovirus which is infectious. “Fragments” according to the present invention relate also to specific fragments of the sequences inserted into the vector pCR4-Topo and deposited as MERV-env, MERV-gag, MERV-prt and MERV-pol as mentioned above. Additionally, methods of using such sequences, polypeptides encoded by such sequences, antibodies directs against such sequences, and methods and compositions relating to the same are all contemplated.
REFERENCES:
patent: 6395549 (2002-05-01), Tuan et al.
patent: 6396549 (2002-05-01), Weber
patent: 6500869 (2002-12-01), Driller et al.
patent: 7256274 (2007-08-01), Noteborn et al.
patent: 19811692 (1999-09-01), None
patent: 9252780 (1997-09-01), None
patent: WO 98/24454 (1998-06-01), None
patent: WO 99/67395 (1999-12-01), None
patent: WO 00/06598 (2000-02-01), None
patent: WO 00/20460 (2000-04-01), None
patent: WO 00/53789 (2000-09-01), None
patent: WO 01/62937 (2001-08-01), None
patent: WO 01/70941 (2001-09-01), None
patent: PCT/EP02/10899 (2003-04-01), None
Balda et al., “Oncornavirus-like particles in human skin cancers,”Proc. Natl. Acad. Sci., USA, 72(9):3697-3700, 1975.
Barbulescu et al., “A HERV-K provirus in chimpanzees, bonobos and gorillas, but not humans,”Current Biology, 11(10):779-783, 2001.
Barbulescu et al., “Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans,” Current Biology, 9(4):861-868, 1999.
Bartlett et al., “Overview of the effectiveness of triple combination therapy in antiretroviral-naïve HIV-1 infectedadults,”AIDS,15(11):1369-1377, 2001.
Birkmayer et al., “Oncorna-viral information in human melanoma,”Europe. J. Cancer, 10:419-422, 1974.
Birkmayer et al., “Virus-like particles in metastases of human malignant melnoma,”Die Naturwissenschaften, 59(8):36-370, 1972.
Burke, “Clearing the way for ribozymes,”Nature Biotechnology, 15:414-415, 1997.
Ferko et al., “Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 nef-specific systemic and mucosal immune responses in mice,”J. Virol., 75(19):8899-8908, 2001.
GenBank Accession No. AF164614.
Komurian-Pradel et al., “Rapid communication molecular cloning anc characterization of MSRV-related sequences associated with retrovirus-like particles,”Virology, 260(1):1-9, 1999.
Kuwabara et al., “Formation of a catalytically active dimer by trna val-driven short ribozymes,”Nature Biotechnology, 16:961-965, 1998.
Löwer et al., “Identification of human endogenous retroviruses with complex mRNA espression and particle formation,”Proc. Natl. Acad. Sci., USA, 90:4480-4484, 1993.
Löwer et al., “The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences,”Proc. Natl. Acad. Sci., USA, 93(11):5177-5184, 1996.
Marimoutou et al., “Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort,”J. Acquir. Immune Defic Syndr., 27(2):161-167, 1996-1998.
Muster et al., “An endogenous retrovirus derived from human melanoma cells,”Cancer Res., 63(24):8735-41, 2003.
Muster et al., “Detection of viral sequences and virus-like particles in human melanoma,” J. Invest. Dermatology, 114(4):860, 2000.
Office Communication, dated Oct. 10, 2006.
Office Communication, dated Sep. 25, 2007.
Office Communication, dated May 29, 2008.
Pooga et al., “Cell penetrating DNA constructs regulate alanin receptor levels and modify transmission in vivo,”Nature Biotechnology, 16:857-861, 1998.
Reus et al., “Genomic organization of the human endogenous retrovirus HERV-K(HML-2.HOM)(ERVK6) on chromosome 7,”Genomics, 72(3):314-320, 2001.
Reus et al., “HERV-K(OLD): ancestor sequences of the human endogenous retrovirus family HERV-K(HML-2),”J. Virol., 75(19) 8917-8926, 2001.
Turner et al., “Insertational polymorphisms of full-length endogenous retroviruses in humans,”Current Biology, 11(19):1531-1535, 2001.
Grassauer Andreas
Muster Thomas
Pehamberger Hubert
Wolff Klaus
Avir Green Hills Biotechnology Research Development Trade AG
Fulbright & Jaworski LLP
Shen Wu-Cheng Winston
LandOfFree
Polynucleotide fragments of an infectious human endogenous... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polynucleotide fragments of an infectious human endogenous..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotide fragments of an infectious human endogenous... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2724505